A 153 (Nifedipine extended release 30 mg)
Pill imprint A 153 has been identified as Nifedipine extended release 30 mg.
Nifedipine is used in the treatment of raynaud's syndrome; high blood pressure; migraine prevention; hypertensive emergency; angina pectoris prophylaxis (and more), and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nifedipine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).
- A 153
- 30 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
polyethylene glycol 8000
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|68084-0142||Amerisource Health Services|
|63739-0451||McKesson Packaging Services|
|67544-1136||Prepak Systems Inc (repackager)|
|21695-0908||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about nifedipine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.